Understanding Infantile Hemangioma
April 29, 2015
“You No Longer Have To Watch and Wait.”
Awareness of Infantile Hemangioma
What could be more frightening than bringing your newborn baby home in perfect health, then noticing a bright red tumor-like growth on your baby’s skin? What’s more frustrating than seeking multiple medical opinions, only to be told “just watch and wait”? Infantile Hemangioma is a common benign growth that affects millions of newborn babies. A small percentage can be dangerous to a child’s health, and many more can leave permanent tissue damage if untreated. Until recently, awareness of Infantile Hemangioma was minimal, and available treatments carried significant side effects. A truly groundbreaking treatment has changed the landscape of Pediatric Dermatology. Leading experts like Dr. Ana Duarte, Founder of the Children’s Skin Center and Head of Dermatology at Miami Children’s Hospital, have called this drug “a true game-changer”. Watch and see how it is changing the lives of families living with Infantile Hemangioma.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.